Navigation Links
Immunotherapy: enlisting the immune system to fight cancer
Date:4/15/2008

rapy. In a phase I trial, they observed that a combination of GVAX immunotherapy with ipilimumab lowered prostate-specific antigen (PSA) levels in some patients.

Higher doses of ipilimumab combined with the GVAX vaccine is showing a lot of success in increasing anti-tumor activity in these patients, said Saskia J.A.M. Santegoets, Ph.D., a researcher in the Department of Pathology and Division of Immunotherapy at the Vrije Universiteit Medical Center in the Netherlands. Were encouraged by the results of this phase I trial and expect ongoing analyses to yield more valuable data about the GVAX/ ipilimumab combination.

In this trial, the vaccine was administered with escalating doses of anti-CTLA-4 (cytotoxic T-lymphocyte antigen 4) antibody ipilimumab. Researchers believe that the combination of these two immunotherapies increases ones immunity to prostate cancer.

Twelve patients were enrolled in this study. All were given the same doses of GVAX (a 500 million cell first dose followed by bi-weekly 300 million-cell doses for 24 weeks), and, in groups of three, different quantities of ipilimumab administered every four weeks (.3mg, 1mg, 3mg, or 5 mg).

Anti-tumor activity was seen in five of the six patients who received the two highest doses of ipilimumab, including PSA-level declines of greater than 50 percent; these PSA declines were maintained in four of these patients for at least six months, and up to 16 months. Among the patients with PSA-level declines, researchers noted complete resolution of multiple lesions on bone scans in two patients, resolution of cancer spread to abdominal lymph nodes in one patient, and improvement in bone pain in one patient.

The ongoing phase I trial of this combination has enrolled an additional 16 patients with hormone-resistant prostate cancer into an expansion cohort.


Evidence of Efficacy of Antibody Directed Enzyme Prodrug Therapy (ADEPT) in a Phase I Tria
'/>"/>

Contact: Staci Vernick Goldberg
Staci.goldberg@aacr.org
267-646-0616
American Association for Cancer Research
Source:Eurekalert

Page: 1 2 3 4 5 6

Related medicine news :

1. Embryonic stem cells could help to overcome immune rejection problems
2. Manipulating the immune system like a parasite
3. Eating Less May Hinder Immune System
4. Video: New Autoimmunity Public Service Campaign Alerts Men About Their Autoimmune Disease Risk
5. Einstein researchers genetically engineer immune cells into potent weapons for battling HIV
6. New protein discovery helps researchers understand autoimmune diseases
7. MedImmune Prepared to Support Implementation of Expanded ACIP Recommendations for Influenza Vaccinations
8. Adult Stem Cells Help Those With Immune Disorders, Heart Disease
9. Prime Your Immune System During the Peak of Cold Season and Beyond
10. Gene therapy trains immune system to destroy brain cancer cells and reverses behavioral deficits
11. Single microRNA fine-tunes innate immune response
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... 2014 NexCore Group has opened its ... by Todd Varney and Justin Pawlak, will allow the ... the benefits and best practices of NexCore’s national healthcare ... local project delivery resources. , With a total ... across the country over the past several years to ...
(Date:9/18/2014)... and young adults who,ve been mentored may be more ... greater responsibility and independence early on in their career, ... having a mentor provides a clear benefit well into ... an associate professor of sociology at North Carolina State ... In conducting the study, published online recently in the ...
(Date:9/18/2014)... to develop broadly effective vaccines to prevent the spread ... limited progress has been made along these lines, there ... most people from these devastating diseases. , So ... working? , At Caltech, Nobel Laureate David Baltimore and ... way. Whereas vaccines introduce substances such as antigens into ...
(Date:9/18/2014)... Greensboro, NC (PRWEB) September 18, 2014 ... it’s also Domestic Violence Awareness Month. And the Centers ... Survey tells a scary story. , According to the ... a fourth of men in the U.S. experience some ... an intimate relationship. The same survey shows that about ...
(Date:9/18/2014)... New York, NY (PRWEB) September 18, 2014 ... retailer in NY, is now offering a 65-80% discount ... , including a whopping 71% off on its 14K ... $2,669, this diamond band can now be bought for ... band is 406147. , Talking about this diamond band, ...
Breaking Medicine News(10 mins):Health News:NexCore Group Opens Regional Office in Orlando, Florida 2Health News: Mentors May Steer Young People Toward More Rewarding Careers 2Health News:A new way to prevent the spread of devastating diseases 2Health News:A new way to prevent the spread of devastating diseases 3Health News:A new way to prevent the spread of devastating diseases 4Health News:A new way to prevent the spread of devastating diseases 5Health News:What you should know about domestic violence 2Health News:What you should know about domestic violence 3Health News:What you should know about domestic violence 4Health News:What you should know about domestic violence 5Health News:ItsHot.com Now Offering 65-80% Discount on its Striking Collection of Diamond Wedding Bands 2
... satisfaction scores at,outpatient health care facilities are on the ... Inc. The 2008 Outpatient Pulse Report: Patient,Perspectives on ... driver for improvement in patient services. The report,includes ... more than,1,200 outpatient care facilities nationwide last year. , ...
... New research has found that the availability of ... emergency room can significantly increase the number of stroke ... the study, conducted at North Shore Medical Center (NSMC)-Salem ... the annual meeting of the Radiological Society of North ...
... San Diego, December 2, 2008 As the connection ... clearer and legislation was passed to reduce such passive ... in the January 2009 issue of the American ... of California, San Francisco, Partners Healthcare, Boston and Columbia ...
... Cells shut down and stop dividing when their DNA ... so as to prevent damaged DNA from leading to ... study, published in this week,s issue of PLoS ... down they also spew proteins into their surrounding environment. ...
... Harnessing miRNA natural gene repressors for anticancer therapy ... Cancer Center, New York, have developed a new approach ... and used this to mediate effective anticancer therapy in ... are powerful natural repressors of gene expression. In the ...
... Tampa Beneficiaries for Par and Poker Celebrity Challenge for Charity , ... The Joyner-Walker Foundation today named the Kid,s Charity of Tampa Bay, ... beneficiaries for the 2009 Par and Poker Celebrity Challenge for Charity ... "It is only appropriate that events like this give ...
Cached Medicine News:Health News:Outpatient Service Facilities Face Increasing Competition - Patient Perceptions More Important Than Ever 2Health News:Portable CT increases chance of stroke survival and recovery 2Health News:Escape cancer, but age sooner? The dark side of the tumor suppressing process 2Health News:JCI online early table of contents: Dec. 1, 2008 2Health News:JCI online early table of contents: Dec. 1, 2008 3Health News:JCI online early table of contents: Dec. 1, 2008 4Health News:Celebrity Event Gives Local Non-Profits a Reason to be Thankful 2
(Date:9/18/2014)... SAN DIEGO , Sept. 18, 2014 /PRNewswire/ ... today announced that the U.S. Food and Drug ... patient enrollment and dosing of PEGPH20 in SWOG,s ... is designed to evaluate Halozyme,s investigational drug PEGPH20 ... FOLFIRINOX chemotherapy (mFOLFIRINOX) in patients with metastatic pancreatic ...
(Date:9/18/2014)... and MELBOURNE, Australia , Sept. ... Biopharma today announced the appointments of Dr. Ashraf ... D.V.M ., M.S., to its Board of Directors. Dr. ... Affairs Finance at Genentech and Chief Financial Officer for ... as Vice President and Global Head of Business Development ...
(Date:9/18/2014)... SYDNEY , Sept. 18, 2014 Australian ... an important US trial of its MiStat™ prostate cancer ... Administration (FDA) regulatory approval upon completion. Minomic,s ... identifying the presence of a proprietary biomarker known as ... surface of prostate cancer cells. Researchers ...
Breaking Medicine Technology:SWOG To Resume Clinical Trial Of Halozyme's PEGPH20 In Combination With Modified FOLFIRINOX For Advanced Pancreatic Cancer 2SWOG To Resume Clinical Trial Of Halozyme's PEGPH20 In Combination With Modified FOLFIRINOX For Advanced Pancreatic Cancer 3SWOG To Resume Clinical Trial Of Halozyme's PEGPH20 In Combination With Modified FOLFIRINOX For Advanced Pancreatic Cancer 4Nexvet Appoints Ashraf Hanna and Joseph McCracken to Board of Directors 2Nexvet Appoints Ashraf Hanna and Joseph McCracken to Board of Directors 3Minomic Launches US Pilot Study of MiStat(TM) Novel Prostate Cancer Screening Technology 2
... , SUNNYVALE, Calif. , Feb 11 ... second fiscal quarter ended December 31, 2009 . , Upon ... ended December 31, 2009 , the company began recognizing revenue under ... April 2009 . Total revenue recognized under GAAP in our most ...
... Mesa Laboratories, Inc. (Nasdaq: MLAB ) today reported sales ... December 31, 2009 . , Highlights: , ... Nine month cash flow provided by operations exceeded $4,882,000 ... six month period over the prior six months. , ...
Cached Medicine Technology:Pharmacyclics Reports Second Quarter Fiscal 2010 Financial Results 2Pharmacyclics Reports Second Quarter Fiscal 2010 Financial Results 3Pharmacyclics Reports Second Quarter Fiscal 2010 Financial Results 4Pharmacyclics Reports Second Quarter Fiscal 2010 Financial Results 5Pharmacyclics Reports Second Quarter Fiscal 2010 Financial Results 6Pharmacyclics Reports Second Quarter Fiscal 2010 Financial Results 7Pharmacyclics Reports Second Quarter Fiscal 2010 Financial Results 8Pharmacyclics Reports Second Quarter Fiscal 2010 Financial Results 9Pharmacyclics Reports Second Quarter Fiscal 2010 Financial Results 10Pharmacyclics Reports Second Quarter Fiscal 2010 Financial Results 11Pharmacyclics Reports Second Quarter Fiscal 2010 Financial Results 12Pharmacyclics Reports Second Quarter Fiscal 2010 Financial Results 13Pharmacyclics Reports Second Quarter Fiscal 2010 Financial Results 14Pharmacyclics Reports Second Quarter Fiscal 2010 Financial Results 15Pharmacyclics Reports Second Quarter Fiscal 2010 Financial Results 16Pharmacyclics Reports Second Quarter Fiscal 2010 Financial Results 17Pharmacyclics Reports Second Quarter Fiscal 2010 Financial Results 18Pharmacyclics Reports Second Quarter Fiscal 2010 Financial Results 19Mesa Labs Reports Quarterly Sales and Earnings 2Mesa Labs Reports Quarterly Sales and Earnings 3Mesa Labs Reports Quarterly Sales and Earnings 4Mesa Labs Reports Quarterly Sales and Earnings 5Mesa Labs Reports Quarterly Sales and Earnings 6
... is designed to easily couple with ... coupling eliminates clumsy time consuming delays. ... well. Dorniers patented isocentric locating arm ... simple using the Dornier Relax+ table, ...
The latex free, hydrophilic Self-Cath Plus is designed for single use, intermittent self-catheterization. The unique hydrophilic coating activates immediately upon exposure to water for fast, clean...
The latex free, hydrophilic Self-Cath Plus is designed for single use, intermittent self-catheterization. The unique hydrophilic coating activates immediately upon exposure to water for fast, clean...
... The Self-Cath Closed System is ... a method for safe, simple catheterization ... urinary tract infections. It includes ... The new EasyOff tear tab ...
Medicine Products: